Listen to the Episode Below (00:30:25)
288: The Big Year | Jack Callicutt, CFO, Galectin Therapeutics
To span the realm of opportunities in biotech is to gaze down an infinite loop of possibilities with no beginning or end—a place seemingly at odds with the environs of more practical-minded finance leaders, who find comfort in the finite. Yet few CFOs likely wield greater influence than those who set down roots in the…